Senior Director, Search & Evaluation Late Ta Lead, Immunology

CSL Behring

Waltham, MA, US
Base: $308,000 - $377,000; bonus/equity: incentive...
Hybrid
15+ years biopharma experience
Phase 2 to marketed asset sourcing
Deep clinical expertise in immunology or hematology
The role is critical to shaping the portfolio through high-impact partnerships and transactions for later-stage external Hematology therapeutic areas

Job Summary

  • The role is critical to shaping the portfolio through high-impact partnerships and transactions for later-stage external Hematology therapeutic areas.
  • Candidates must possess deep clinical expertise in Immunology, Hematology, or Cardiovascular/Renal therapeutic areas with an advanced degree.
  • This hybrid position requires being onsite three days a week at either the Waltham MA or King of Prussia PA office.

Matching Summary

The role is critical to shaping the portfolio through high-impact partnerships and transactions for later-stage external Hematology therapeutic areas.

Salary

Base: $308,000 - $377,000; Bonus/Equity: Incentive compensation and equity included; Benefits: Not specified

Skills & Requirements

Must-have

  • 15+ years biopharma experience
  • Phase 2 to marketed asset sourcing
  • Deep clinical expertise in Immunology or Hematology
  • Advanced degree MD or PhD required
  • External Key Opinion Leader engagement

Nice-to-have

  • Strong understanding of regulatory pathways
  • Experience with market access strategies
  • Proven track record closing late-stage deals
  • Ability to anticipate competitive dynamics

Key Requirements

  • 15+ years in biopharma
  • MD, PhD, or equivalent degree
  • Late-stage deal sourcing experience

Work Rights

Not specified

Tailored Resume

Cover Letter